(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
Arecor Therapeutics PLC - Essex, England-based biopharmaceutical company - Signs exclusive formulation study collaboration with an unnamed pharmaceutical company, under which Arecor will use its formulation technology platform Arestat to develop liquid formulations of its proprietary products. Read More
Arecor Therapeutics PLC - Essex, England-based biopharmaceutical company - Says it is making progress with two lead clinical stage programmes focused on diabetes. Says phase one clinical trial data for both lead product, AT247, an ultra-rapid insulin and for second product AT278, a concentrated rapid insulin targeting patients who require higher volumes of insulin, "excelled our expectations". Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
